HOME >> BIOLOGY >> NEWS
Biofuel economics

Second generation biorefineries those making biofuel from lignocellulosic feedstocks like straw, grasses and wood have long been touted as the successor to todays grain ethanol plants, but until now the technology has been considered too expensive to compete. However, recent increases in grain prices mean that production costs are now similar for grain ethanol and second generation biofuels, according to a paper published in the first edition of Biofuels, Bioproducts & Biorefining.

The switch to second generation biofuels will reduce competition with grain for food and feed, and allow the utilization of materials like straw which would otherwise go to waste. The biorefineries will also be able to use lignocellulosic crops like poplar and switchgrass, which can be grown on land less suitable for farming than traditional row crops. These findings should be a boost to companies hoping to establish themselves in this emerging field.

Two researchers working at the Department of Mechanical Engineering at Iowa State University set out to compare the capital and operating costs of generating fuel from starch and cellulose-containing materials.

They showed that the capital costs for 150 million gallon gasoline equivalent capacity range from around $111 million for a conventional grain ethanol plant to $854 million for an advanced (Fischer Tropsch) plant. The difference in the final cost of the fuel, however, was less severe, being $1.74 for grain ethanol when corn costs $3.00 per bushel and $1.80 for cellulosic biofuel when biomass costs $50 per ton.

The authors compared biochemical and thermochemical approaches to biofuels. They showed that both have much higher capital costs than conventional grain ethanol plants, but that neither had a significant cost advantage over the other.

Comparing the costs of biofuels is complicated by the fact that most studies rarely employ the same bases for economic evaluations. Difference
'"/>

Contact: Jennifer Beal
wbnewseurope@wiley.co.uk
44-012-437-70633
John Wiley & Sons, Inc.
8-Aug-2007


Page: 1 2

Related biology news :

1. BioMed Central announces new interdisciplinary Biofuels Journal
2. Biofuels: More than just ethanol
3. Biofuel cells without the bio cells
4. High-value chemicals produced from ethanol feedstocks could boost biorefinery economics
5. Linking empires, economics, evolution

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biofuel economics

(Date:11/4/2014)... (Nov. 4, 2014) – A majority of Madagascar,s 101 ... could have serious consequences for the rainforests they call ... the positive impacts lemurs can have on rainforest tree ... disappearance could have on the region,s rich biodiversity. , ... fruits eaten by lemurs. Lemurs in turn disperse ...
(Date:11/3/2014)... DUBLIN , Nov. 3, 2014 Research ... report "Cell Therapy - Technologies, Markets and Companies" ... evaluates cell therapy technologies and methods, which have already started ... Hematopoietic stem cell transplantation is replacing the old fashioned bone ... described. Cell therapy is bound to become a part of ...
(Date:11/3/2014)... 3, 2014  NeuroSigma ® , Inc. (NeuroSigma), ... company focused on commercialization of its non-invasive ... treatment of neurological and neuropsychiatric disorders, announced today ... issued a Notice of Allowance for Mexican Patent ... by NeuroSigma and the Regents of the University ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
(Date:11/21/2014)... 20, 2014 The report, ... Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, ... Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to ... drivers, threats, opportunities, and challenges. , Browse ... spread through 185 pages and in-depth TOC ...
(Date:11/21/2014)... Why did Stephen Hawking become so famous? ... recognizable? Why have they become icons to rival film ... Ratcliffe seeks out the answers to those questions, and ... with science. In " Stephen Hawking Smoked My Socks ... Ratcliffe puts it plainly: , “It is profoundly ...
(Date:11/21/2014)... Polaris Group announced today that the ... 1 trial of ADI-PEG 20 in combination with ... pleural mesothelioma (MPM) and non-squamous non-small cell lung ... ADI-PEG 20, both as monotherapy and in combination ... other indications, including breast cancer, melanomas, ovarian cancer, ...
(Date:11/21/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results ... 2014.  Biorem,s complete 2014 third quarter financial statements and MD&A have ... ended September 30, , Nine-months ended September ... 2014 , 2013 , 2014 , ... , 6,715 , 14,476 Gross profit , ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
Cached News: